Wells Fargo’s Epizyme, Inc EPZM Stock Holding History

Wells Fargo’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-18,200	Closed	-$7K	–	6872
2019 Q2	$7K	Buy	+18,200	New	+$234K	﹤0.01%	5991

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Wells Fargo's EPZM Position: Q3 2022 in Review

Wells Fargo sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 1,015 shares — an estimated $1K sold.

Wells Fargo first reported a position in EPZM in Q3 2013 and held it in 35 quarters. The position peaked at $1.64M in Q3 2019. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

Wells Fargo reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
Wells Fargo sold 1,015 Epizyme, Inc shares in Q3 2022, an estimated $1K.
Wells Fargo first reported a position in Epizyme, Inc in Q3 2013 and held it in 35 quarters.
Wells Fargo's Epizyme, Inc position peaked at $1.64M in Q3 2019.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on Wells Fargo's 13F filing for Q3 2022, filed 14 Nov 2022.